These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 17910895

  • 1. Opioids and migration, chemotaxis, invasion, and adhesion of human cancer cells.
    Zagon IS, Rahn KA, McLaughlin PJ.
    Neuropeptides; 2007 Dec; 41(6):441-52. PubMed ID: 17910895
    [Abstract] [Full Text] [Related]

  • 2. Opioids and differentiation in human cancer cells.
    Zagon IS, McLaughlin PJ.
    Neuropeptides; 2005 Oct; 39(5):495-505. PubMed ID: 16169076
    [Abstract] [Full Text] [Related]

  • 3. Opioid growth factor (OGF) inhibits anchorage-independent growth in human cancer cells.
    Zagon IS, McLaughlin PJ.
    Int J Oncol; 2004 Jun; 24(6):1443-8. PubMed ID: 15138586
    [Abstract] [Full Text] [Related]

  • 4. Opioids and the apoptotic pathway in human cancer cells.
    Zagon IS, McLaughlin PJ.
    Neuropeptides; 2003 Apr; 37(2):79-88. PubMed ID: 12747939
    [Abstract] [Full Text] [Related]

  • 5. Direct effects of delta opioid receptor agonists on invasion-associated activities of HCT-8/E11 colon cancer cells.
    Debruyne D, Leroy A, DE Wever O, Vakaet L, Mareel M, Bracke M.
    Anticancer Res; 2010 Jan; 30(1):9-17. PubMed ID: 20150612
    [Abstract] [Full Text] [Related]

  • 6. T lymphocyte proliferation is suppressed by the opioid growth factor ([Met(5)]-enkephalin)-opioid growth factor receptor axis: implication for the treatment of autoimmune diseases.
    Zagon IS, Donahue RN, Bonneau RH, McLaughlin PJ.
    Immunobiology; 2011 May; 216(5):579-90. PubMed ID: 20965606
    [Abstract] [Full Text] [Related]

  • 7. Reepithelialization of the human cornea is regulated by endogenous opioids.
    Zagon IS, Sassani JW, McLaughlin PJ.
    Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):73-81. PubMed ID: 10634604
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of the opioid growth factor receptor potentiates growth inhibition in human pancreatic cancer cells.
    Zagon IS, Verderame MF, Hankins J, McLaughlin PJ.
    Int J Oncol; 2007 Apr; 30(4):775-83. PubMed ID: 17332915
    [Abstract] [Full Text] [Related]

  • 9. The opioid growth factor (OGF) and low dose naltrexone (LDN) suppress human ovarian cancer progression in mice.
    Donahue RN, McLaughlin PJ, Zagon IS.
    Gynecol Oncol; 2011 Aug; 122(2):382-8. PubMed ID: 21531450
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. B lymphocyte proliferation is suppressed by the opioid growth factor-opioid growth factor receptor axis: Implication for the treatment of autoimmune diseases.
    Zagon IS, Donahue RN, Bonneau RH, McLaughlin PJ.
    Immunobiology; 2011 Aug; 216(1-2):173-83. PubMed ID: 20598772
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (Carcinoembryonic Antigen).
    Blumenthal RD, Hansen HJ, Goldenberg DM.
    Cancer Res; 2005 Oct 01; 65(19):8809-17. PubMed ID: 16204051
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Nucleocytoplasmic distribution of opioid growth factor and its receptor in tongue epithelium.
    Zagon IS, Ruth TB, McLaughlin PJ.
    Anat Rec A Discov Mol Cell Evol Biol; 2005 Jan 01; 282(1):24-37. PubMed ID: 15584033
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.